AML in adult patients who are long-term survivors: physical, social and molecular genetic study

1. Compare overall survival between AML long-term survivors (patients older than 18 years at diagnosis where the disease is in long-term remission (i.e. > 3 years after diagnosis) and the general swedish population matched for gender and age.
2. Describe the physical status of these patients by routine functional organ-specific blood tests.
3. Investigate quality of life, social conditions and mental health of these patients (e.g. working/not, existence of partner/cohabitation, sex life, smoking, alcohol habits, drug use, presence/not and grading of depression)
4. Describe molecular genetics of AML in long-term survivors